AzTrials
AzTrials

SleepNCT06487650

The Development and Evaluation of Sleep Intervention for Perinatal Family

A study testing sleep intervention in people with Sleep and Psychological Distress, run by Taipei Medical University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Background: Sleep disruptions and disturbances are highly prevalent among new mothers and fathers and negatively affect their mental health and infant development outcomes. Effective sleep interventions are vital for family health. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
Conditions the study is for
Sleep, Psychological Distress, Perinatal Problems
What is being tested?
sleep intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
No sites listed yet
Study dates
Dec 2025to Sep 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • First-time mothers and their partners aged 20 and older;
  • Currently 30 weeks gestation or more, singleton;
  • insomnia severity index score greater than 10;
  • living with a husband or partner;
  • Both women and their partners are willing to participate in and adhere to the research protocol;
  • be able to read and speak the Mandarin language

Who cannot join

  • sleep disorders, depression or anxiety disorders;
  • medical diseases with abnormal heart rate variability, or arrhythmia;
  • taking medicines that may affect the autonomic nervous system or
  • night shift workers;
  • obstetric complications, including gestational hypertension, preterm labor, labor complications, or postpartum complications;
  • infants with fetal deformity, or neonatal complications;
  • no access to Internet resources

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Background: Sleep disruptions and disturbances are highly prevalent among new mothers and fathers and negatively affect their mental health and infant development outcomes. Effective sleep interventions are vital for family health.

Objectives: To develop a sleep intervention for mother-father-infant triads, and to evaluate the effects on sleep improvement, emotional distress, and infant health outcomes.

Read more

Methods: In this proposal, we plan to conduct a parallel-group two-arm randomized controlled trial on pregnant women and their partners. Mother-father-infant triads will be recruited and randomly allocated to the intervention group (receiving a sleep intervention) or the control group. Data will be collected with repeated measures, and the relationship between studied variables will be analyzed with descriptive and inferential statistics.

Anticipatory results: The development and evaluation of an evidence-based sleep intervention will provide a scientific insight into sleep care for pregnant women and their families.

Read the detailed description

The primary outcome is the severity of insomnia symptoms. The secondary outcomes of parents' sleep quality, objective sleep indicators, symptoms of depression and anxiety, and heart rate variability will be collected. Infant sleep quality, infant feeding, and infant health outcomes will also be assessed. Data will be analyzed using descriptive and inferential statistics.

Being tested
sleep intervention, Control group
Keywords
sleep quality, perinatal, depression, anxiety, infant sleep, infant health
Medical subject headings
Sleep Initiation and Maintenance Disorders, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sleep interventionBehavioural

    At the beginning of the intervention, participants will have an orientation and overview of the program. Then, participants will follow the curriculum of modules, and professional feedback to complete the intervention.

  • Control groupBehavioural

    Participants in control group will follow standardized usual care and a perinatal health booklet

Study groups in NCT06487650
Study groupRoleWhat they receive
sleep interventionExperimentalParticipants in the intervention group will receive both the standardized usual care and the sleep intervention. The intervention consists of sleep education, health professional support, and counseling. The intervention will be delivered from pregnancy to postpartum for mothers and fathers.
Receives: Behavioral: sleep intervention
ControlActive comparatorParticipants in the control group will receive a perinatal health booklet in addition to the standardized usual care.
Receives: Behavioral: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insomnia Severity Index

    The Chinese version of the Insomnia Severity Index (ISI) is used to measure the severity of insomnia symptoms, a higher score indicates more severe insomnia symptoms.

    Measured: baseline, at 36-weeks' gestation, 2-week postpartum, 1-month, 3-month,6-month, and 12-month postpartum

Secondary outcomes (14)
  1. Sleep quality

    The 19-item Chinese version of the Pittsburgh Sleep Quality Index (PSQI), will be used to measure sleep quality and sleep disturbance, higher score indicates worse sleep quality

    Measured: baseline, at 36-weeks' gestation, postpartum 1 month, 3 months, 6 months, and 12-months

  2. Sleep duration using actigraphy

    The Actiwatch will be used to collect objective data of sleep duration

    Measured: baseline, postpartum 1 month, 3 months, and 6 months.

  3. Sleep sleep onset latency using actigraphy

    The Actiwatch will be used to collect objective data of sleep onset latency

    Measured: baseline, postpartum 1 month, 3 months, and 6 months.

  4. Sleep efficacy using actigraphy

    The Actiwatch will be used to collect objective data of sleep efficacy

    Measured: baseline, postpartum 1 month, 3 months, and 6 months.

  5. Wake after sleep onset using actigraphy

    The Actiwatch will be used to collect objective data of wake after sleep onset

    Measured: baseline, postpartum 1 month, 3 months, and 6 months.

  6. Infants sleep Questionnaire

    Parents will be asked to rate their infant's sleep quality using the 19-item Brief Infant Sleep Questionnaire-Revised (BISQ-R). The BISQ will be used to assess sleep duration, duration of sleep by circadian rhythm, and night-time awakenings

    Measured: postpartum 1 month, 3 months, 6 months, and 12-months

  7. Depressive symptoms

    Maternal and paternal depressive symptoms will be assessed using the Taiwanese version of the 10-item Edinburgh Postnatal Depression Scale (EPDS), a higher score indicated more severe symptoms.

    Measured: baseline, at 36-weeks' gestation, postpartum 1 month, 3 months, 6 months, and 12-months

  8. Anxiety symptoms

    The 20-item State Anxiety subscale of the State-Trait Anxiety Inventory (STAI) will be used to measure levels of anxiety symptoms in mothers and fathers, higher score presents more severe symptoms.

    Measured: baseline, at 36-weeks' gestation, postpartum 1 month, 3 months, 6 months, and 12-months

  9. Heart rate variability (HRV) measures

    The resting interbeat interval will be recorded

    Measured: at baseline, postpartum 1 month, 3 months, and 6 months

  10. Infant weight

    Infants' body weight in gram will be measured by trained data collectors using an electronic scale specifically for infants

    Measured: postpartum 3 months, 6 months, and 12-months

  11. Infant height

    Infants' height in cm will be measured by trained data collectors using an electronic scale specifically for infants

    Measured: postpartum 3 months, 6 months, and 12-months

  12. Infant development

    Infant's social and emotional development will be assessed using the Taiwanese version of the Ages \& Stages Questionnaires: Social-Emotional-2 (ASQ: SE-2).

    Measured: postpartum 3 months, 6 months, and 12-months

  13. Infant feeding

    Infant feeding methods will be measured using a self-report questionnaire. The feeding methods, including initiated breastfeeding within 24 hours after birth, and type of breastfeeding.

    Measured: postpartum 1 month, 3 months, and 6 months, and 12 months

  14. Satisfaction of sleep intervention

    A structured questionnaire with a 5-point Likert scale will be used to collect the level of satisfaction of the sleep intervention upon completion of programs.

    Measured: immediately after interventions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2024
  2. Study startDec 2025 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06487650
Sponsor's protocol ID
N202204079
Status last verified
Jan 2025
First submitted
13 Jun 2024
Last updated
14 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in